CPT code 17262 covers the destruction of malignant cutaneous lesions on the trunk, arms, or legs measuring 1.1 cm to 2.0 cm in diameter, using methods such as chemosurgery, cryosurgery, electrosurgery, or comparable destructive techniques. This code is important for clinicians and billing professionals because it defines a specific lesion size range and scope of service that influences coding accuracy, coverage determinations, and claims adjudication on a national level. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will learn the clinical context for when 17262 is used, the typical settings where the service is performed, and the payer landscape that commonly adjudicates these services. The publication provides benchmarks and policy-relevant observations for nationwide practice, highlights differences in payer coverage language and prior authorization trends where available, and outlines common billing considerations tied to lesion size and technique. The content is intended to support accurate coding, efficient claims submission, and informed payer engagement for services involving malignant lesion destruction on the trunk, arms, or legs.